Stämmler, Frank
Derain-Dubourg, Laurence
Lemoine, Sandrine
Meeusen, Jeffrey W.
Dasari, Surendra
Lieske, John C.
Robertson, Andrew
Schiffer, Eric
Article History
Received: 8 September 2022
Accepted: 23 March 2023
First Online: 31 March 2023
Declarations
:
: The study was conducted according to the guidelines of the Declarations of Helsinki and Istanbul, and was approved by the relevant Institutional Review Boards (Mayo Clinic IRB# 19–003513, dated 16 May 2019, and Hospital Edouard Herriot IRB# DC-2012–1615, dated 2 July 2012. All individuals gave informed consent before joining the study.
: Not applicable.
: F.S., A.R. and E.S. report personal fees from numares AG, outside the submitted work. numares AG is a diagnostics company and focuses on the discovery, development, and commercialization of diagnostic tests by metabolite constellations. E.S. has a patent application WO002020065092A1 pending. All other authors have declared that no conflict of interest exists.